Intuitive (ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today provided an update on its efforts to support customers, communities, and its employees during the COVID-19 pandemic. Intuitive and the Intuitive Foundation are working to assemble, donate, and distribute personal protective equipment (PPE) to hospitals and healthcare facilities. The Intuitive Foundation is also connecting employees with opportunities to volunteer in their communities.

Here's why the leading surgical robot company -- and its stock -- will do well in a post-pandemic world.

Nothing feeds fear in the stock market like uncertainty, and nothing spreads fear and uncertainty like a global pandemic. As coronavirus worries infected the financial markets, stocks tumbled at a record pace. Standard & Poor's 500-stock index dropped 34% from its all-time high in about a month. During the Great Recession, it took nearly a year for the index to decline by that amount. A near-total economic shutdown in the country's biggest cities compounded the damage. "These are unprecedented times," says Philip Lawlor, managing director, global markets research at FTSE Russell.But smart investors are greedy when others are fearful, and this time is no different. Fidelity Puritan fund manager Dan Kelley and other fund managers have been busy buying during the sell-off. "Opportunities like these come along once a decade if you're lucky," says Kelley, who says he's finding some of the best investment opportunities he has seen in a long time. Just because a stock is cheap doesn't mean it's a bargain. Stocks in high-quality firms--financially strong, well-established firms with lots of cash and little debt--are better equipped to withstand troubled times and rough markets. Some even emerge from a crisis stronger. With that in mind, we set out to find stocks with staying power, focusing on firms that lead their industry and have a competitive advantage over peers, a steady history of profitability and good long-term growth prospects. We list our six favorites below. SEE ALSO: 20 Best Stocks to Buy for the Next Bull Market

Fund reveals 1st-quarter trades Continue reading...

Q1 2020 Intuitive Surgical Inc Earnings Call

In the wake of Intuitive Surgical's stronger-than-expected earnings report, UBS cut its share-price target, SVB Leerink cut its rating but lifted its price target, and Stifel boosted its price target.

Blue Hawk Investment Group, LLC is the management company of the Blue Hawk Fundamental Growth Fund, LP. Insider Monkey has recently published a copy of Blue Hawk Investment Group’s Q1 2020 investor letter. A copy of the letter can be downloaded here. Jake DuBois is the fund’s founder and managing member. The fund was founded in […]

Wells Fargo Growth Fund is one of IBD's 2020 best mutual funds. It bought stock in medical device makers amid the coronavirus stock market correction.

Intuitive (ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the election of Joseph C. Beery to its board of directors, effective April 23, 2020. “Joe has broad experience leading digital business capabilities, computing and information technology within global organizations, and we look forward to his insights and contributions as we expand our capabilities,” said Intuitive CEO Gary Guthart. Beery was senior vice president of Information Technology and Chief Information Officer for Thermo Fisher Scientific, a life sciences company, until his retirement in September 2019.

Intuitive Surgical got a key stock upgrade Tuesday, as its Relative Strength (RS) Rating climbed above the 80 mark to an 81 rating, and its stock surged higher. The company earlier cautioned though that it's second half 2020 outlook was murky due to current market volatility. The stock upgrade to an 81 RS Rating puts Intuitive Surgical stock into rarefied territory.

ISRG stock has skidded this year, leading Intuitive Surgical stock performance to lag its peers in its medical technology group. So, is it time to take on this robotic surgery stock?

The company is facing headwinds, and it's performing slightly worse than the market. Is it worth the price?

Ensemble Capital, an independently-owned investment firm, recently published its first-quarter Ensemble Fund commentary – a copy of which can be downloaded here. During the first quarter of 2020, the Ensemble Fund returned -18.6%, while the benchmark S&P 500 was down 19.6%. In the said letter, Ensemble Capital highlighted a few stocks and Intuitive Surgical Inc (NASDAQ:ISRG) […]

Shares of Intuitive Surgical inched up late Thursday after the robotic surgery giant beat first-quarter sales and earnings expectations. The company didn't issue guidance for 2020.

Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted that a US recession is imminent and US stocks will go down by at least 20% in the next 3-6 […]

A Relative Strength Rating upgrade for Intuitive Surgical shows improving technical performance. Will it continue?

Motley Fool co-founder David Gardner revisits three Five-Stock Samplers and offers up lessons he learned to help you invest better.

Intuitive Surgical (ISRG) first-quarter results benefit from strong growth across all businesses and higher revenues.

These healthcare stocks are already dominant, and it should remain that way for a long time to come.

Pioneer of robot-assisted surgery, Intuitive Surgical (ISRG), has announced first quarter 2020 revenue of $1.1 billion, beating consensus estimates by $90 million and marking 13% year-over-year growth. On the news, ISRG shares rose 6% higher in Friday’s pre-market trading.Meanwhile Q1 Non-GAAP EPS of $2.69 beat the Street’s expectations by $0.15, with GAAP EPS of $2.62 beating by $0.53.According to Intuitive Surgical, higher first quarter revenue was driven by increased procedures and systems placements as well as higher service and operating lease revenue.Worldwide procedures for its da Vinci robotic surgical system grew approximately 10% compared with the first quarter of 2019, with 237 da Vinci Surgical Systems shipped in the first quarter of 2020.For the first two and a half months of the first quarter of 2020, procedure performance was trending at the higher end of our expectations, says ISRG.“However… the Company experienced a significant decline in procedure volume and postponements of system placements in the latter half of March in the U.S. and Western Europe, as healthcare systems in those areas diverted resources to meet the increasing demands of managing COVID-19” the company stated.Looking ahead, Intuitive Surgical told investors that it cannot now reliably estimate the future impact of the coronavirus pandemic on its operations and financial results.But Bank of America’s Bob Hopkins remains optimistic about the company’s long-term prospects. “ISRG may face a challenging 12 months (our 2021 EPS estimate is 12% below consensus and further downside cannot be ruled out), but in our view, the company could end up even more dominant on the other side" he said.With this in mind, the analyst reiterated his buy rating with a $650 price target (27% upside potential). In the last three months, 10 analysts have published buy ratings on ISRG vs 1 hold rating and 2 sell ratings, giving the stock its Moderate Buy analyst consensus. (See Intuitive Surgical’s stock analysis on TipRanks)Related News: Gilead Shares Rise On Early Peek At Positive Covid-19 Vaccine Data Novavax To Commence Australia’s First COVID-19 Vaccine Trial Roku Topped Estimates, but Uncertainty Lies Ahead More recent articles from Smarter Analyst: * Diamond Offshore Drilling Files For Chapter 11 Bankruptcy Amid Oil Crash * Domino’s Pizza Sees U.S. Comparable Sales Boost, Suspends Outlook * Peloton Shares Spike on Record Participants in Live Streaming Cycling Class * Apple Prepares to Sell Macs With Its Own Chips in 2021